We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Stahl Online is a one-stop shop, covering everything a mental health professional or teacher will ever need to know about neuropsychopharmacology. Comprehensive and regularly updated, Stahl Online provides full access to the entire current portfolio of books by Dr Stephen M. Stahl.
Stahl Online is a one-stop shop, covering everything a mental health professional or teacher will ever need to know about neuropsychopharmacology. Comprehensive and regularly updated, Stahl Online provides full access to the entire current portfolio of books by Dr Stephen M. Stahl.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
As an excellent source of learning for prescribers specializing in psychiatry, primary care physicians, nurse practitioners, psychologists, and pharmacists, this new edition features approximately 150 questions, divided into ten core areas of psychiatry, helping to identify areas in which you need further study. The majority of questions are new or updated in their explanations and referencing. Each question is followed by an explanation of the answer and a list of references. After completing the questions you will be better able to: diagnose patients presenting with psychiatric symptoms using accepted diagnostic standards and practices; implement evidence-based psychiatric treatment strategies aligned with the patient's recovery goals; integrate recent advances in diagnostic and treatment strategies into clinical practice according to best practice guidelines. This collection has been approved by the American Board of Psychiatry and Neurology as part of a lifelong learning and self-assessment program and as a component of maintenance of certification.
This full-color, practical handbook provides a concise, evidence-based psychopharmacological approach to the management of complex treatment-resistant psychotic disorders. Part I focuses uniquely on topics and strategies relevant to treating this challenging patient population. These approaches go beyond standard guidelines while adhering to research and clinically derived data. Part II provides a concise array of information regarding those classes of medications most commonly used when treating complex treatment-resistant psychotic disorders. Each medication guide contains sections including mechanisms of action, typical treatment response, monitoring, dosing and kinetics, medications to avoid in combination/warnings, and take-home pearls. Part III offers tips in brief appendix chapters for managing common issues ranging from loading lithium and valproic acid to the treatment of acute psychomotor agitation. An essential resource for psychiatrists, forensic clinicians, psychiatric trainees, and all mental health professionals involved with, or interested in, the treatment of challenging psychotic disorders.
Despite the lack of guidance available for practitioners, extensive polypharmacy has become the primary method of treating patients with severe and chronic mood, anxiety, psychotic or behavioral disorders. This ground-breaking new book provides an overview of psychopharmacology knowledge and decision-making strategies, integrating findings from evidence-based trials with real-world clinical presentations. It adopts the approach and mind-set of a clinical investigator and reveals how prescribers can practice 'bespoke psychopharmacology', tailoring care to the individualized needs of patients. Practitioners at all levels of expertise will enhance their ability to devise rationale-based treatments, targeting manifestations of dysfunctional neural circuitry and dimensions of psychopathology that cut across conventional psychiatric diagnoses. Presented in a user-friendly, practical, full-colour layout and incorporating summary tables, bullet points, and illustrative case vignettes, it is an invaluable guide for all healthcare professionals prescribing psychotropic medications, including psychiatry specialists, primary care physicians, and advanced practice registered nurses.
Reports reveal an increase in the number of individuals with serious mental illness in jails, prisons and forensic hospitals. Despite the wide-ranging and devastating consequences of this 'criminalization' of mental illness, there remains a lack of information on the subject as well as on the provision of care for these patients. This important new book fills a gap in the literature by examining topics such as: the history and policy factors related to criminalization; original research on forensic populations; pharmacological and psychological treatment strategies; and principles and guidelines for diversion out of the criminal justice system. Contributions from leading experts in the field further our understanding of this important subject, offering advice on how to provide humane care for patients. A must have for all mental health clinicians including psychiatrists, psychologists, social workers, rehabilitation therapists, and mental health nurses. A useful tool for mental health administrators and policy makers.
The association between violence and mental illness is well studied, yet remains highly controversial. Currently, there does appear to be a trend of increasing violence in hospital settings, including both civilly and forensically committed populations. In fact, physical aggression is the primary reason for admission to many hospitals. Given that violence is now often both a reason for admission and a barrier to discharge, there is a pressing need for violence to be re-conceptualized as a primary medical condition, not as the by-product of one. Furthermore, treatment settings need to be enhanced to address the new types of violence exhibited in inpatient environments and this modification needs to be geared toward balancing safety with treatment. This book focuses on violence from assessment, through underlying neurobiology, to treatment and other recommendations for practice. This will be of interest to forensic psychiatrists, general adult psychiatrists, psychiatric residents, psychologists, psychiatric social workers and rehabilitation therapists.
As an excellent source of learning for prescribers specializing in psychiatry, primary care physicians, nurse practitioners, psychologists, and pharmacists, this new edition features approximately 150 questions, divided into ten core areas of psychiatry, helping you to identify areas in which you need further study. The majority of questions are new or updated in their explanations and referencing. Each question is followed by an explanation of the answer and a list of references. After completing the questions you will be better able to: diagnose patients presenting with psychiatric symptoms using accepted diagnostic standards and practices; implement evidence-based psychiatric treatment strategies aligned with the patient's recovery goals; integrate recent advances in diagnostic and treatment strategies into clinical practice according to best practice guidelines. This collection has been approved by the American Board of Psychiatry and Neurology as part of a lifelong learning and self-assessment program and as a component of maintenance of certification.
The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.